BWXT's TRISO Fuel Achieves First Criticality, Validating Advanced Nuclear Optionality

What happened

BWX Technologies announced that its TRISO nuclear fuel enabled Antares Nuclear's reactor to achieve first criticality under the DOE's Executive Order 14301, marking a key milestone for advanced reactor testing. This confirms BWXT's manufacturing capability and supports the Project Pele timeline, a core narrative catalyst. However, the investment thesis remains contingent on converting the $2.15B unfunded U.S. Government backlog into funded work to meet FY2026 guidance. While this milestone strengthens the optionality argument, it does not resolve appropriations timing risk that underpins our WAIT rating. The news is positive but insufficient to justify the current P/E of 65.6 and EV/EBITDA of 41.9.

Implication

The TRISO success adds credibility to the advanced nuclear catalyst, supporting a potential bull case if funded backlog also converts. However, the valuation already prices in such optionality, so any slippage in funding or execution could lead to downside.

Thesis delta

This milestone confirms that BWXT's TRISO fuel is operational, increasing the probability of the Bull scenario (20% probability, implied value $280) but does not change the base case dependency on backlog conversion. The core thesis remains that the stock is priced for near-flawless execution on backlog conversion; this event is a positive for optionality but not a thesis changer.